Skip to main content
Erschienen in: Urolithiasis 4/2022

09.06.2022 | Original Article

Primary hyperoxaluria and genetic linkages: an insight into the disease burden from Pakistan

verfasst von: Seema Hashmi, Aiysha Abid, Sajid Sultan, Sualeha Siddiq Shekhani, Ali Asghar Lanewala, Mirza Naqi Zafar

Erschienen in: Urolithiasis | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Autosomal recessive disorders are prevalent in Pakistan, a developing South Asian country where consanguineous marriages are common. This study seeks to determine the prevalence of monogenic causes in children presenting with nephrocalcinosis and nephrolithiasis at a dialysis and transplant center in Karachi, Pakistan. A retrospective analysis was conducted in children aged 1–18 years presenting with nephrocalcinosis, between 2010 and 2019. Demographic information, clinical profile, laboratory parameters and stone analysis were collected, on a pre-designed questionnaire. One hundred and twenty-six children were included, with 11 and 3 diagnosed with renal tubular acidosis and Bartter’s syndrome respectively. Next-generation sequencing and Sanger sequencing was performed on 112 children. Eighty-seven patients were diagnosed with primary hyperoxaluria, with mutations in alanine–glyoxylate-aminotransferase gene found in 73, followed by glyoxylate reductase/hydroxy-pyruvate reductase in 13, and 4-hydroxy-2-oxaloglutarate aldolase in 1. Twenty-five patients reported negative for mutations. Sixty-four percent were males, with a statistically significant difference (p < 0.05). History of parental consanguineous marriage was found in 98% of the cohort. Fifty-four and 40 patients presented to the clinic with Chronic Kidney Disease Stage 1 and Stage 5, respectively, with a statistically significant difference p = 0.007. Mutations noted in our cohort are different and more severe than those reported in the developed world. The disease poses a major disease burden in developing world context with the only treatment option of combined liver–kidney transplantation not available in Pakistan.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Braun DA, Hildebrandt F (2016) Prevalence of monogenic causes in pediatric patients with nephrolithiasis and nephrocalcinosis. Clin J Am Soc Nephrol 11:664–672CrossRef Braun DA, Hildebrandt F (2016) Prevalence of monogenic causes in pediatric patients with nephrolithiasis and nephrocalcinosis. Clin J Am Soc Nephrol 11:664–672CrossRef
2.
Zurück zum Zitat Giovanna P (2017) Understanding the pathophysiology of Nephrocalcinosis. IntechOpen Giovanna P (2017) Understanding the pathophysiology of Nephrocalcinosis. IntechOpen
3.
Zurück zum Zitat Hunter DJ, Lange M (2002) Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (London) 103:259–265CrossRef Hunter DJ, Lange M (2002) Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (London) 103:259–265CrossRef
4.
Zurück zum Zitat Goldfarb DS, Fischer ME, Keich Y, Goldberg J (2005) A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67:1053–1061CrossRef Goldfarb DS, Fischer ME, Keich Y, Goldberg J (2005) A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67:1053–1061CrossRef
5.
Zurück zum Zitat Milliner DS (2015) Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int 87:623–631CrossRef Milliner DS (2015) Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int 87:623–631CrossRef
6.
Zurück zum Zitat Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I (2010) Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 87(3):392–399CrossRef Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I (2010) Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 87(3):392–399CrossRef
7.
Zurück zum Zitat Soliman NA, Nabhan MM, Abdelrahman SM (2017) Clinical spectrum of primary hyperoxaluria type1. Experience of a tertiary care center. Nephrol Ther 13(3):176–182CrossRef Soliman NA, Nabhan MM, Abdelrahman SM (2017) Clinical spectrum of primary hyperoxaluria type1. Experience of a tertiary care center. Nephrol Ther 13(3):176–182CrossRef
8.
Zurück zum Zitat Hoppe B, Latta K, von Schnakenburg C (2005) Primary hyperoxaluria-the german experience. Am J Nephrol 25:276–281CrossRef Hoppe B, Latta K, von Schnakenburg C (2005) Primary hyperoxaluria-the german experience. Am J Nephrol 25:276–281CrossRef
9.
Zurück zum Zitat Frishberg Y, Rinat C, Rumsby G (2005) Intra-Familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol 25:269–275CrossRef Frishberg Y, Rinat C, Rumsby G (2005) Intra-Familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol 25:269–275CrossRef
10.
Zurück zum Zitat Rizvi SA, Sultan S et al (2016) Pediatric urolithiasis in emerging economies. Int J Surg 36:705–712CrossRef Rizvi SA, Sultan S et al (2016) Pediatric urolithiasis in emerging economies. Int J Surg 36:705–712CrossRef
11.
Zurück zum Zitat Talati JJ, Hulton S-A, Garrelfs S, Aziz W (2018) Primary hyperoxaluria in population of Pakistan origin: result from a literature review and two major registries. Urolithiasis 46:187–195CrossRef Talati JJ, Hulton S-A, Garrelfs S, Aziz W (2018) Primary hyperoxaluria in population of Pakistan origin: result from a literature review and two major registries. Urolithiasis 46:187–195CrossRef
12.
Zurück zum Zitat Amar A, Majmundar AJ, Ullah I, Afzal A, Hildebrandt F (2019) Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Human Genet 138(3):211–219CrossRef Amar A, Majmundar AJ, Ullah I, Afzal A, Hildebrandt F (2019) Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Human Genet 138(3):211–219CrossRef
13.
Zurück zum Zitat Habbig S, Bernd H et al (2011) Nephrocalcinosis and urolithiasis in children. Kidney Int 80:1278–1291CrossRef Habbig S, Bernd H et al (2011) Nephrocalcinosis and urolithiasis in children. Kidney Int 80:1278–1291CrossRef
14.
Zurück zum Zitat Halbritter J, Michelle B, Hildebrandt F (2015) Fourteen monogenic genes account for 15% of nephrolithiasis /nephrocalcinosis. J Am Soc Nephrol 26(3):543–551CrossRef Halbritter J, Michelle B, Hildebrandt F (2015) Fourteen monogenic genes account for 15% of nephrolithiasis /nephrocalcinosis. J Am Soc Nephrol 26(3):543–551CrossRef
15.
Zurück zum Zitat Shekhani SS, Lanewala AA (2021) Ethical challenges in dialysis and transplantation: perspectives from the developing world. Semin Nephrol 41(3):211–219CrossRef Shekhani SS, Lanewala AA (2021) Ethical challenges in dialysis and transplantation: perspectives from the developing world. Semin Nephrol 41(3):211–219CrossRef
19.
Zurück zum Zitat Hamamy H (2012) Consanguineous marriages. Preconception consultation in primary healthcare settings. J Community Genet 3(3):185–192CrossRef Hamamy H (2012) Consanguineous marriages. Preconception consultation in primary healthcare settings. J Community Genet 3(3):185–192CrossRef
20.
Zurück zum Zitat Gargah T, Khelil N, Youssef G (2011) Primary hyperoxaluria type1 in Tunisian children. Tunis Med 89:163–167PubMed Gargah T, Khelil N, Youssef G (2011) Primary hyperoxaluria type1 in Tunisian children. Tunis Med 89:163–167PubMed
21.
Zurück zum Zitat Harambat J, Fargue S, Acquaviva C, Cochat P (2010) Genotype-phenotype correlation in primary hyperoxaluria type 1: the p. Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 77:443–449CrossRef Harambat J, Fargue S, Acquaviva C, Cochat P (2010) Genotype-phenotype correlation in primary hyperoxaluria type 1: the p. Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 77:443–449CrossRef
22.
Zurück zum Zitat Rumsby G, Williams E, Coulter-Mackie M (2004) Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 66:959–963CrossRef Rumsby G, Williams E, Coulter-Mackie M (2004) Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 66:959–963CrossRef
23.
Zurück zum Zitat Milosevic D, Rinat C, Batinic D, Frishberg Y (2002) Genetic analysis—a diagnostic tool for primary hyperoxaluria type 1. Pediatric Nephrol 17:896–898CrossRef Milosevic D, Rinat C, Batinic D, Frishberg Y (2002) Genetic analysis—a diagnostic tool for primary hyperoxaluria type 1. Pediatric Nephrol 17:896–898CrossRef
24.
Zurück zum Zitat Milliner DS, Wilson DM, Smith LH (2001) Phenotypic expression of primary hyperoxaluria: comparative features of type 1 and 2. Kidney Int 59:31–36CrossRef Milliner DS, Wilson DM, Smith LH (2001) Phenotypic expression of primary hyperoxaluria: comparative features of type 1 and 2. Kidney Int 59:31–36CrossRef
25.
Zurück zum Zitat Liebow A, Li X, Racie T, Hettinger J (2017) An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria. J Am Soc Nephrol 28(2):494–503CrossRef Liebow A, Li X, Racie T, Hettinger J (2017) An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria. J Am Soc Nephrol 28(2):494–503CrossRef
26.
Zurück zum Zitat Gambaro G, Ferraro MP (2011) Ayurvedic medicine and NADPH oxidase: a possible approach to the prevention of ESRD in hyperoxaluria. Nephrol Dial Transpl 26(6):1759–1761CrossRef Gambaro G, Ferraro MP (2011) Ayurvedic medicine and NADPH oxidase: a possible approach to the prevention of ESRD in hyperoxaluria. Nephrol Dial Transpl 26(6):1759–1761CrossRef
Metadaten
Titel
Primary hyperoxaluria and genetic linkages: an insight into the disease burden from Pakistan
verfasst von
Seema Hashmi
Aiysha Abid
Sajid Sultan
Sualeha Siddiq Shekhani
Ali Asghar Lanewala
Mirza Naqi Zafar
Publikationsdatum
09.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 4/2022
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-022-01338-x

Weitere Artikel der Ausgabe 4/2022

Urolithiasis 4/2022 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.